Compare Moderna, Inc. (MRNA) vs Trade Desk Inc (TTD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Trade Desk Inc — how do they compare? Moderna, Inc. trades at $60.75 (market cap $24.18B), while Trade Desk Inc trades at $13.52 (market cap $6.37B). The key difference: Moderna, Inc. is far larger — about 3.8× Trade Desk Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Trade Desk Inc nearer its low. Which is the better fit depends on your goals.
| MRNA | TTD | |
|---|---|---|
Market Cap | $24.18B | $6.37B |
Sector | Health | Technology |
52-Week High | $81.80 | $55.36 |
52-Week Low | $22.36 | $13.39 |
Enterprise Value | $20.33B | $5.32B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Trade Desk Inc
The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.
Read more on TTD →
